METiS Pharmaceuticals to Participate in SAPA-China 2024 Pharma Industry Conference in Suzhou
METiS TechBio
AI-Driven Drug Formulation Developer
“SAPA-China 2024 Pharmaceutical Industry Conference -- Promoting Innovation and Collaboration, Accelerating Industry Integration"Will be in 2024October 18-19InSuzhou · Lion Mountain International Convention CenterHost.
More than 7,000 scholars from top global research institutions, as well as leading figures from large multinational pharmaceutical and biotech innovation enterprises, will attend the conference. The event will focus on hot topics such as large/small molecules, cell and gene therapy, AI drug discovery, nucleic acids, GLP-1 and metabolism, clinical trials, radiopharmaceutical conjugates, international collaboration, investment and financing, and more. It will feature high-level forums, thematic sessions, project matchmaking, financing presentations, and company exhibitions. This is not only an international academic and product conference connecting the entire pharmaceutical industry chain—from innovative research, applied studies, clinical trials, regulation, manufacturing, to sales—but also an excellent platform for the integration of capital and projects.
As a representative of a global leading "AI + Drug Delivery" company，METiS TechBio(METiS Pharmaceuticals)RecipientInvited to attend this meeting.Song Liujun, Head of BD / Vice President of METiS TechBio ChinaWill chair the "Sub-venue Four: Artificial Intelligence Accelerates Innovative Drug Development" on the afternoon of October 19th (Saturday), and deliver a speech titled "AI-Driven Lipid Discovery and Development"The Theme Report."
(METiS TechBioLink)
Related Reading:
Focus on "AI + Drug Delivery," METiS TechBio Completes $100 Million Series C Financing
